Search Bar & Filters
Found 2 Actively Recruiting clinical trials
Actively Recruiting
Researchers are investigating whether online transdiagnostic cognitive behavior therapy CBT can more effectively reduce symptoms compared to usual primary care for adults with common mental disorders such as anxiety, depression, and stress-related conditions. This randomized controlled trial aims to build evidence for an accessible, resource-efficient treatment option delivered through a secure web platform. The study also evaluates quality of life, functional impairment, neuroticism, treatment moderators, mediators, and cost-effectiveness. Participants are randomly assigned to receive either online transdiagnostic CBT or usual primary care. The online CBT involves modules with psychoeducation, worksheets, exercises, and weekly written feedback from a therapist mainly through messages on the platform. Some participants may have up to three face-to-face or video sessions for support. Those in usual care receive standard treatment provided by general practitioners or other primary care professionals without intervention control by the study. Participants will be assessed at baseline and followed through week 10, with additional follow-ups at 1 and 2 years. Assessments include symptom scales such as the Depression Anxiety Stress Scales-21 DASS-21, quality of life, work ability, and sickness absence. Researchers will monitor symptom changes and other outcomes to compare treatments. Participation involves completing online modules, questionnaires, and possible clinical interviews, with the study lasting up to two years for follow-up assessments.
Actively Recruiting
Researchers are investigating whether online transdiagnostic cognitive behavioral therapy CBT can improve symptoms in adults with subsyndromal mental ill-health in a primary care setting. This trial compares the effects of this online CBT to usual primary care treatments in patients experiencing anxiety, depressive symptoms, or stress-related issues that do not meet criteria for a specific psychiatric disorder. The study aims to evaluate symptomatic improvements, quality of life, functional ability, neuroticism, and cost-effectiveness of the online treatment compared to standard care. Participants will be randomly assigned to either online transdiagnostic CBT or primary care as usual. The online CBT is delivered through a secure web platform featuring modules with psychoeducation, worksheets, and exercises. Therapists provide weekly written feedback and gradually give access to treatment modules, primarily communicating through messages within the platform. Some face-to-face or video sessions may be offered for technical help and support. Those in the usual care group receive standard health services available in primary care, which are expected to include active treatment but are not controlled by the study. During the trial, participants complete assessments measuring symptoms using the Depression Anxiety Stress Scales-21 DASS-21 at baseline, weeks 2, 4, 6, 8, 10, and at 1- and 2-year follow-ups. Additional measures include quality of life, work ability, sickness absence, and neuroticism scales collected at similar intervals. The study tracks progress and evaluates the effectiveness of treatments over time with a target enrollment of 500 participants. Participation involves completing questionnaires and engaging with the assigned treatment or usual care for approximately 10 weeks with extended follow-up assessments.